CBER STUDY DATA STANDARDS UPDATE

Similar documents
Material covered in the Dec 2014 FDA Binding Guidances

Study Data Technical Conformance Guide (TCG)

STUDY DATA TECHNICAL CONFORMANCE GUIDE

Preparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA

FDA Study Data Technical Conformance Guide v4.2

Comparison of FDA and PMDA Requirements for Electronic Submission of Study Data

PhUSE Paper SD09. "Overnight" Conversion to SDTM Datasets Ready for SDTM Submission Niels Mathiesen, mathiesen & mathiesen, Basel, Switzerland

Lex Jansen Octagon Research Solutions, Inc.

Study Data Reviewer s Guide

Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA

POLICY AND PROCEDURES OFFICE OF SURVEILLANCE AND EPIDEMIOLOGY. Procedures for Handling Requests for Proprietary Name Review.

Implementing CDISC Using SAS. Full book available for purchase here.

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...

Traceability Look for the source of your analysis results

DIA 11234: CDER Data Standards Common Issues Document webinar questions

Study Data Reviewer s Guide Completion Guideline

Considerations on creation of SDTM datasets for extended studies

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets

ectd TECHNICAL CONFORMANCE GUIDE

Revision of Technical Conformance Guide on Electronic Study Data Submissions

CDISC SDTM and ADaM Real World Issues

The Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008

OpenCDISC Validator 1.4 What s New?

Updates on CDISC Standards Validation

Creating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS

Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area

Taming the SHREW. SDTM Heuristic Research and Evaluation Workshop

PharmaSUG Paper DS16

Study Data Reviewer s Guide. FDA/PhUSE Project Summary

Recent Developments in FDA s Review of Proprietary Names for Drugs

Standards Metadata Management (System)

Lex Jansen Octagon Research Solutions, Inc.

Out-of-the-box %definexml

Optimizing the Use of Data Standards CSS Summary

PharmaSUG Paper PO22

Unique Device Identification (UDI) Status, Learnings, Next Steps

Paper DS07 PhUSE 2017 CDISC Transport Standards - A Glance. Giri Balasubramanian, PRA Health Sciences Edwin Ponraj Thangarajan, PRA Health Sciences

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library

PMDA Valida+on Rules. Preparing for your next submission to Japanese Pharmaceu6cals and Medical Devices Agency. Max Kanevsky December 10, 2015

Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC

PharmaSUG Paper CD16

Aquila's Lunch And Learn CDISC The FDA Data Standard. Disclosure Note 1/17/2014. Host: Josh Boutwell, MBA, RAC CEO Aquila Solutions, LLC

Streamline SDTM Development and QC

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

How to write ADaM specifications like a ninja.

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes

Experience of electronic data submission via Gateway to PMDA

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams

An Alternate Way to Create the Standard SDTM Domains

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards

Codelists Here, Versions There, Controlled Terminology Everywhere Shelley Dunn, Regulus Therapeutics, San Diego, California

Biotechnology Industry Organization 1225 Eye Street NW, Suite 400 Washington, DC 20006

Automate Analysis Results Metadata in the Define-XML v2.0. Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc.

A CMC Reviewer s Perspective on the Quality Overall Summary. Arthur B. Shaw, Ph.D. FDA/CDER/ONDQA FDA DMF Expert June 15, 2010.

Standards Driven Innovation

Step Up Your ADaM Compliance Game Ramesh Ayyappath & Graham Oakley

Dealing with changing versions of SDTM and Controlled Terminology (CT)

SIMPLIFY AND STREAMLINE USING PYTHON

MEDICINES CONTROL COUNCIL

Legacy to SDTM Conversion Workshop: Tools and Techniques

Touchstone Technologies, Inc. Course Catalog February 2017

The ectd Backbone Files Specification for Module 1. The ectd BACKBONE FILES SPECIFICATION FOR MODULE 1

Dataset-XML - A New CDISC Standard

esubmission - Are you really Compliant?

GDUFA s Impact on ectds / Case Study: Implementing PDF Standards

Bay Area CDISC Network: PhUSE Working Group for Inspection Site Selection Data Standards

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA

Conversion of Company Standard Trial Data to SDTM

Automated Creation of Submission-Ready Artifacts Silas McKee, Accenture, Pennsylvania, USA Lourdes Devenney, Accenture, Pennsylvania, USA

Common Protocol Template (CPT) Frequently Asked Questions

Introduction to ADaM and What s new in ADaM

Standards Implementation: It Should be Simple Right? Thursday January 18, 2018

Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development

Topics Raised by EFPIA. Webinar on Policy Jun 2017, FINAL. Presentation

A SDTM Legacy Data Conversion

SAS Clinical Data Integration 2.6

Global Checklist to QC SDTM Lab Data Murali Marneni, PPD, LLC, Morrisville, NC Sekhar Badam, PPD, LLC, Morrisville, NC

WHODrug B3- and C3-formats

Data Quality Project Open Industry Meeting. Steven Wilson, BSI. What can we do to find lost customers and why do we want to do it?

SAS Clinical Data Integration 2.4

SDTM Attribute Checking Tool Ellen Xiao, Merck & Co., Inc., Rahway, NJ

Paper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA

CDISC Standards and the Semantic Web

BUSINESS-BASED VALUE IN AN MDR

Best Practice for Explaining Validation Results in the Study Data Reviewer s Guide

CDISC Nutrition Therapeutic Area User Guide Public Review Webinar

Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA

Common Programming Errors in CDISC Data

Cost-Benefit Analysis of Retrospective vs. Prospective Data Standardization

ICH Topic M 4 Common Technical Document for the Registration of Pharmaceuticals for Human Use Organisation CTD. Step 5

ADaM Reviewer s Guide Interpretation and Implementation

The Submission Data File System Automating the Creation of CDISC SDTM and ADaM Datasets

Data Consistency and Quality Issues in SEND Datasets

Prove It! Importance and Methodologies of Validation in Clinical Trials Reporting

Optimization of the traceability when applying an ADaM Parallel Conversion Method

Introduction to Define.xml

A Taste of SDTM in Real Time

LOUGHBOROUGH UNIVERSITY RESEARCH OFFICE STANDARD OPERATING PROCEDURE. Loughborough University (LU) Research Office SOP 1027 LU

Standardizing FDA Data to Improve Success in Pediatric Drug Development

How to review a CRF - A statistical programmer perspective

Transcription:

CBER STUDY DATA STANDARDS UPDATE Lisa Lin, MBA Study Data Standards Manager Office of the Director Center for Biologics Evaluation and Research U.S. Food & Drug Administration PhUSE US Connect Raleigh, NC Jun 4, 2018 1

FDA Disclaimer The views and opinions presented here represent those of the speaker and should not be considered to represent advice or guidance on behalf of the U.S. Food and Drug Administration. 2

CBER Updates for Standardized Study Data Standardized Data Submission Metrics New Data Standards Staff has been established Standardized Study Data Validation - SDTM datasets - ADaM datasets - Define.xml - ISS and ISE datasets

CBER Updates for Standardized Study Data Implementation of Study Data Standardization Plan (SDSP CBER appendix) Vaccine TAUG & Vaccine Technical Specifications Document Training programs & Consultation Service to CBER reviewers SEND (Standard for Exchange of Nonclinical Data) project, evaluation and testing of the SEND standard for CBER

CBER Standardized Data Submission Metrics 80 Standardized Data Submission Rate (Percentage) 70 60 50 40 30 Standardized Data Submission Rate (Percentage) 20 10 0 CY2013 CY2014 CY2015 CY2016 CY2017 5

CBER Data Standards Staff CBER Office of Director Review Management Data Standards Staff (Virginia Hussong) Office of Biostatistics & Epidemiology (OBE) Office of Blood Research & Review (OBRR) Office of Vaccine Research & Review (OVRR) Office of Tissue & Advanced Therapies (OTAT) Office of Compliance & Biologics Quality (OCBQ)

Standardized Study Data Validation New validation process in place starting the end of 2017 DataFit validation for all incoming BLAs, Supplements Ensure study data meets the standards, in good quality for review Help review division issue Information Request (IR) or Refuse to File (RTF) if needed 7

Standardized Study Data Validation Information Request Examples Issue 1 The xxxx and xxxx studies are missing the AE, CE and CM domains, even though the SUPPAE, SUPPCE and SUPPCM domains have been provided. The reviewer's guides do not explain why these domains are missing. The reviewer's guides and define.xml document the AE, CE and CM domains, explain validation rules, etc. Issue 2 File names: most supporting documents (e.g. reviewer's guides, protocols, etc.) hyperlinked within the define.xml files have the incorrect filename listed in the hyperlink. All the documents appear to be present, however, they can only be opened manually rather than using the hyperlinks in the define.xml). Please correct the file names so that the hyperlinks are functional. 8

Study Data Validation Information Request Examples Issue 3 In study xxx, 126 (3.6%) events are missing start date/time. Please insert the missing information. Issue 4 Some of the values in EXSTDTC is not ISO8601 format, -----T19:00, so EXSTDY has missing value. This needs to be fixed. 9

Study Data Standardization Plan (SDSP) Study Data Technical Conformance Guide recommends sponsors to include a plan (eg. in the IND) describing the submission of standardized study data to FDA for clinical and nonclinical studies SDSP assists FDA in identifying potential data standardization issues early in the development program CBER recommends sponsor to submit SDSP no later than the end-of-phase 2 meeting PhUSE (Pharmaceutical Users Software Exchange) has developed a SDSP template for sponsors to follow https://www.phuse.eu/css-deliverables 10

Study Data Standardization Plan (SDSP) CBER SDSP appendix should include tables of proposed SDTM domain/variable usage, supplemental domain usage and proposed analysis SDSP is a working document, the cover letter accompanying a study data submission should describe the latest version of SDSP 11

Vaccine TAUG and Vaccine Technical Specifications Vaccine TAUG has been republished by CDISC 04/10/18 https://www.cdisc.org/standards/therapeuticareas/vaccines Vaccine Technical Specifications Document has been published by CBER FDA 04/19/18, webinar was held 05/08/18 https://www.fda.gov/downloads/biologicsbloodvaccin es/guidancecomplianceregulatoryinformation/guidan ces/general/ucm605147.pdf These will be added to Study Data Technical Conformance Guide future release 12

Vaccine Technical Specifications 13

Training Program & Consultation Service to CBER Reviewers Joint effort with CDER to leverage existing training resources - Study Data Standards - JMP - JMP Clinical - MAED Develop CBER specific Study Data Standards Training which will be held in October Provide consultation service to CBER reviewers on study data review and analysis 14

SEND Project SEND (Standard for Exchange of Nonclinical Data) Background: CDER requires SEND for Single Dose Toxicity, Repeat Dose Toxicity and Carcinogenicity studies in NDAs and BLAs for studies initiated after 12/17/16; INDs for studies initiated after 12/17/17 SEND is not required by CBER at this time Next Steps: Evaluation and Testing of the SEND standard for CBER is one of the CBER & CDER Joint Data Standards Program Action Plan projects to improve efficiency in the review process for nonclinical toxicology studies

SEND Project Next Steps: (Cont.) Collect requirements from dedicated CBER nonclinical Pharmacologist Reviewers CDISC sub-team is formed to discuss CBER specific data points and data models to be added in SENDIG, regular telecon is scheduled to decide on the scope and charter of the project, and to create CDISC project request Once the project is chartered, a call for participation will be made to SEND (and possibly SDTM) team members Evaluate tools for analyzing SEND Data Pilot to have sponsor to submit SEND data to CBER

Conclusion CBER works closely with CDER to leverage their combined resources, talent and expertise to maximize stakeholder collaboration, policy development, and project implementation to develop and use data standards for the effective and efficient review of submissions of safety and efficacy data. 17

References Send your questions to CBER: cber_cdisc@fda.hhs.gov FDA Data Standards Catalog: https://www.fda.gov/forindustry/datastandards/studyda tastandards/default.htm Study Data for Submission to CDER and CBER: https://www.fda.gov/forindustry/datastandards/studyd atastandards/ucm587508.htm Study Data Technical Conformance Guide: https://www.fda.gov/downloads/forindustry/datastanda rds/studydatastandards/ucm384744.pdf 18

Any Questions? THANK YOU! Lisa Lin OD/CBER/FDA Wei.Lin@fda.hhs.gov